Moleculin Biotech Cash from Operations (TTM) Analysis

Moleculin Biotech Inc (MBRX)

4.45 -0.07 (-1.62%) USD | NASDAQ | Apr 19, 16:00

4.45 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-24.10M
September 30, 2023	-25.95M
June 30, 2023	-25.98M
March 31, 2023	-28.85M
December 31, 2022	-27.64M
September 30, 2022	-24.64M
June 30, 2022	-21.35M
March 31, 2022	-20.13M
December 31, 2021	-18.95M
September 30, 2021	-17.82M
June 30, 2021	-18.90M
March 31, 2021	-17.05M
December 31, 2020	-17.77M
September 30, 2020	-19.32M
June 30, 2020	-17.28M

Date	Value
March 31, 2020	-17.69M
December 31, 2019	-17.20M
September 30, 2019	-15.63M
June 30, 2019	-15.12M
March 31, 2019	-13.24M
December 31, 2018	-12.20M
September 30, 2018	-11.48M
June 30, 2018	-10.28M
March 31, 2018	-8.74M
December 31, 2017	-7.324M
September 30, 2017	-6.103M
June 30, 2017	-5.443M
March 31, 2017	-4.866M
December 31, 2016	-3.765M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-28.85M

Minimum

Mar 2023

-15.12M

Maximum

Jun 2019

-20.60M

Average

-18.95M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks